This Week in Cardiology Podcast Por Medscape arte de portada

This Week in Cardiology

This Week in Cardiology

De: Medscape
Escúchala gratis

This podcast delivers Dr. John Mandrola's summary and perspective on top news of the week that cardiologists can't miss. This podcast is intended for US health professionals only.Copyright 2019, Medscape Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Apr 10 2026 This Week in Cardiology

    Apr 10 2026 This Week in Cardiology
    Apr 10 2026

    Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I IVUS-Guided PCI

    • OPTIMAL Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2600440
    • IVUS-CHIP Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2601521
    • ILUMIEN IV Trial https://www.nejm.org/doi/10.1056/NEJMoa2305861
    • DKCRUSH VIII Trial https://doi.org/10.1016/j.jacc.2026.01.081

    II Ez-PAVE Trial — Low vs Very Low LDL-targets

    Does Ez-PAVE Support 'Lower Is Better' for LDL-C? https://www.medscape.com/viewarticle/does-ez-pave-support-lower-better-ldl-c-2026a1000akx

    • Ez-PAVE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2600283
    • 2026 ACC/AHA Lipid Guidelines https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423

    III CORALreef AddOn

    • CORALreef AddOn Trial https://www.jacc.org/doi/abs/10.1016/j.jacc.2026.03.036
    • This Week in Caardiology 2-6-26 https://www.medscape.com/viewarticle/1003240
    • CORALreef Lipids Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2511002

    IV Another Post-MI Beta-blocker Withdrawal Study: SMART-DECISION

    • SMART-DECISION Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2601005
    • ABYSS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net
    Más Menos
    32 m
  • Apr 03 2026 This Week in Cardiology

    Apr 03 2026 This Week in Cardiology
    Apr 3 2026

    John Mandrola offers an ACC recap of 5 big trials—Hi-PEITHO, PROTAVI, ORBITA-CTO, CHIPS-BCIS3 and CHAMPION AF

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Catheter Based Fibrinolysis of Pulmonary Embolism –Hi PEITHO

    • Fibrinolysis Treatment Validated in Large Trial for Acute Intermediate-Risk PE https://www.medscape.com/viewarticle/fibrinolysis-treatment-validated-large-trial-acute-2026a10009im
    • Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism (HI PEITHO) https://www.nejm.org/doi/full/10.1056/NEJMoa2516567
    • National Early Warning Score (NEWS) https://www.england.nhs.uk/ourwork/clinical-policy/sepsis/nationalearlywarningscore/

    II PRO-TAVI trial

    • Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI) 10.1016/S0140-6736(26)00308-9 External Link
    • PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation (Notion 3) https://www.nejm.org/doi/full/10.1056/NEJMoa2401513

    III ORBITA CTO Sham vs PCI for Angina Relief

    • Tightly Blinded Trial Confirms PCI Reduces Angina in Obstructive Occlusion https://www.medscape.com/viewarticle/tightly-blinded-trial-confirms-pci-reduces-angina-2026a10009ob
    • A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina - ORBITA-CTO https://www.jacc.org/doi/10.1016/j.jacc.2026.03.027
    • ORBITA 1 10.1016/S0140-6736(17)32714-9 External Link
    • ORBITA 2 https://www.nejm.org/doi/full/10.1056/NEJMoa2310610
    • DECISION CTO https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.031313
    • EuroCTO https://doi.org/10.1093/eurheartj/ehy220

    IV CHIPS BCIS3 Impella Supported High-Risk PCI

    • Adoption Before Evidence: CHIP-BCIS3 Humbles Impella https://www.medscape.com/viewarticle/adoption-before-evidence-chip-bcis3-humbles-impella-2026a10009jh
    • Left Ventricular Unloading in High-Risk PCI (CHIP BCIS3) https://www.nejm.org/doi/full/10.1056/NEJMoa2515704
    • Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock (DanGer Shock) https://www.nejm.org/doi/full/10.1056/NEJMoa2312572

    V CHAMPION AF – Watchman vs DOAC in Patients With AF

    • CHAMPION-AF Trial Finds LAAC an Alternative for NOAC in Lower-Risk Patients https://www.medscape.com/viewarticle/champion-af-trial-finds-laac-alternative-noac-lower-risk-2026a10009ij
    • Six Reasons Why CHAMPION-AF Should Not Change Practice https://www.medscape.com/viewarticle/six-reasons-why-champion-af-should-not-change-practice-2026a10009i7
    • Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation (CHAMPION AF) https://www.nejm.org/doi/full/10.1056/NEJMoa2517213
    • Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation (CLOSURE AF) https://www.nejm.org/doi/full/10.1056/NEJMoa2513310

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net
    Más Menos
    44 m
  • Mar 27 2026 This Week in Cardiology

    Mar 27 2026 This Week in Cardiology
    Mar 27 2026

    Early aortic valve replacement in aortic stenosis, left atrial appendage occlusion in JAMA Cardiology, and a big preview of the upcoming American College of Cardiology meeting are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Early AVR

    • RECOVERY Trial at 10 Years https://www.nejm.org/doi/full/10.1056/NEJMoa2511920

    II Major Bleeding with Amulet and Watchman in JAMA Cardiology

    • Amulet IDE Trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2847047
    • 5-year Results From Amulet IDE https://www.jacc.org/doi/10.1016/j.jacc.2024.10.101

    III ACC Preview

    Mandrola's Top 4 Trials from ACC 2026: Details Matter

    https://www.medscape.com/viewarticle/mandrolas-top-4-trials-acc-2026-details-matter-2026a10008ti

    • CHIB-BCIS3 Trial https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.123.013367
    • Champion-AF Protocol https://doi.org/10.1016/j.ahj.2023.05.022
    • ORBITA-CTO Protocol Paper https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1172763/full
    • SPIRIT-HF Clinical Trials.gov https://clinicaltrials.gov/study/NCT04727073

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net
    Más Menos
    26 m
Todas las estrellas
Más relevante
Dr Mandrola delivers excellent updates on recent publications. The podcast is just the thing for a commute: not too superficial, not too detailed, and do a great job placing the new clinical advances in the context of contemporary practice.

recommend to colleagues

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
As a former Cardiology PA now working on the academic side of medicine, I’ve been out of practice for several years. Preparing to teach a cardiology course at a new program, I started brushing up on material—and stumbled across Dr. Mandrola’s podcast. Wow. I wish I had known about this resource back when I was still practicing clinically.

In just a short time, I’ve learned what’s new since I left practice, and even picked up on things I probably should have known better back then. More importantly, I’ve gained an entirely new appreciation for how to critically review clinical trials and recognize bias.

What sets this podcast apart is Dr. Mandrola’s humility and honesty: his willingness to point out flaws in studies, to admit when he doesn’t know something, and to change his perspective when the evidence supports it. That kind of intellectual honesty builds trust, and it makes him feel less like a distant expert and more like a fellow learner walking through the field with you.

I’ve flown through the last two years of episodes in just a week, and I’m looking forward to being a dedicated listener moving forward. Thank you, Dr. Mandrola, for approaching cardiology not as a lecture, but as a thoughtful, ongoing conversation.

Honest, Insightful, and Incredibly Valuable

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
I absolutely love listening to this podcast and feel I practice medicine very similarly. I love your critical review of studies as it brings these areas to light. I especially loved your comment at the end of this podcast discussing the reasoning to go into EP. I agree with your reasons, and consider them the same for most fields of medicine, especially any in cardiology, which I practice as a PA in and have for 14 years. Going into medicine just for the money should never be the reason as it will only lead to frustration and burnout. Thank you for your honest reviews and feedback each week.

EP is not about the money -love this statement

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
Me gusta el escepticismo del Dr Mandrola. Habla de su objetividad y su compromiso con la ciencia bien hecha

Muy informativo

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.